These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6756171)

  • 21. Left ventricular asynergy during intracoronary isoproterenol infusion in dogs.
    Ilebekk A; Lekven J; Kiil F
    Am J Physiol; 1980 Nov; 239(5):H594-600. PubMed ID: 7435635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs.
    Li HG; Jones DL; Yee R; Klein GJ
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1654-62. PubMed ID: 8238576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiocirculatory dynamics in the normal and failing heart.
    Zelis R; Flaim SF; Liedtke AJ; Nellis SH
    Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
    Nishimura T; Kita S; Abiko Y
    J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furosemide and the progression of left ventricular dysfunction in experimental heart failure.
    McCurley JM; Hanlon SU; Wei SK; Wedam EF; Michalski M; Haigney MC
    J Am Coll Cardiol; 2004 Sep; 44(6):1301-7. PubMed ID: 15364336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy.
    Engler R; Pouleur H; Link J; Printz M; Covell JW
    Clin Exp Hypertens A; 1982; 4(4-5):639-59. PubMed ID: 7049441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs.
    Vatner SF; McRitchie RJ; Maroko PR; Patrick TA; Braunwald E
    J Clin Invest; 1974 Sep; 54(3):563-75. PubMed ID: 4152859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
    Nikolaidis LA; Trumble D; Hentosz T; Doverspike A; Huerbin R; Mathier MA; Shen YT; Shannon RP
    Eur J Heart Fail; 2004 Jun; 6(4):409-19. PubMed ID: 15182765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2,3,7,8-tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts.
    Canga L; Paroli L; Blanck TJ; Silver RB; Rifkind AB
    Mol Pharmacol; 1993 Dec; 44(6):1142-51. PubMed ID: 8264550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
    Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL
    Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC; Roebel LE; Hsieh CP; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent desensitization of the heart to the inotropic action of isoproterenol by adenosine.
    Newman WH; Lee JT; Webb JG
    Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):233-54. PubMed ID: 2602656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The force-frequency relationship in human heart failure: effect of pyruvate and isoproterenol.
    Martisiene I; Gendviliene V; Zablockaite D; Gurskaite H
    Rocz Akad Med Bialymst; 2005; 50():241-3. PubMed ID: 16358975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of effects of dobutamine and ouabain on left ventricular contraction and relaxation in closed-chest dogs.
    Little WC; Rassi A; Freeman GL
    J Clin Invest; 1987 Sep; 80(3):613-20. PubMed ID: 3624480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside.
    Vatner SF; Higgins CB; Patrick T; Franklin D; Braunwald E
    J Clin Invest; 1971 Dec; 50(12):2585-95. PubMed ID: 5129310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of acetylcholine, isoproterenol, quinidine and ouabain on effective refractory periods of atrial and ventricular myocardium in the dog.
    Farges JP; Ollagnier M; Faucon G
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):206-19. PubMed ID: 907407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships among cardiac inotropic responses to norepinephrine and cardiac and blood concentrations of H3-norepinephrine during hypothermia.
    Cotten MV; Logan ME; Moore JI
    J Pharmacol Exp Ther; 1967 Feb; 155(2):231-41. PubMed ID: 4381639
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological studies of a new 4-aminosugar cardiac glycoside (ASI-222).
    Caldwell RW; Nash CB
    J Pharmacol Exp Ther; 1976 Apr; 197(1):19-26. PubMed ID: 1263129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DOCA administration and atrial natriuretic factor in dogs with chronic heart failure.
    Villarreal D; Freeman RH; Brands MW
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H739-45. PubMed ID: 2528918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.